The headline “OxyContin maker will stop promoting opioids to doctors” would be more encouraging to those concerned with the opioid crisis if it weren’t for the manufacturer’s own November 2016 S.W.O.T. (Strengths, Weaknesses, Opportunities, Threats) analysis, published in the EBSCOhost Business Source Complete database.
Under “Opportunities” Purdue Pharma, maker of OxyContin, states “positive outlook for global pain management market.” In other words, the company is simply going to take its aggressive marketing overseas so billions instead of just millions can be exposed to the drug.
Under “Threats” is noted “increasing labor costs in the U.S.,” describing the trend of increasing the minimum wage in various parts of the U.S. This from a privately-held company whose owners, the Sackler family, came in at No. 19 on Forbes’ annual list of America’s richest families in 2016.
The purpose of pharmaceuticals should be to help people, not ruin their lives for the sake of corporate profit.
Kate Bradley, Sammamish